Retrospective Study of the use of Moxidectin in the Treatment of Canine Demodicosis at the Veterinary Hospital of Sao Paulo State University - UNESP - Jaboticabal Campus - Brazil
WSAVA 2002 Congress
*Marlos Goncalves Sousa, Daniel Guimaraes Gerardi, Andrea Cristina Higa, Pedro Paulo Vissoto de Paiva Diniz, Mirela Tinucci Costa, Aparecido Antonio Camacho
*Universidade Estadual Paulista - UNESP - Campus de Jaboticabal
Jaboticabal, Sao Paulo, BR
marlos98@yahoo.com

OBJECTIVES

The objective of this study is to evaluate the efficacy of moxidectin in the treatment of Canine Demodicosis, performing a retrospective study of its use at the diagnosed cases at the Veterinary Hospital of Sao Paulo State University - UNESP - Jaboticabal Campus.

MATERIALS

Since January 2000, Moxidectin has been widely used to treat Canine Demodicosis at the Veterinary Hospital of UNESP - Jaboticabal Campus. Since then until March 2002, 57 cases of this disease were diagnosed, of whom 51 were treated with Moxidectin, using a dose of 0,5 to 1,0 mg/kg each 3 days, per oral, for at least 30 days.

RESULTS

Among the 51 animals that received this medication, 41,17% showed improvement, as well as regression of skin lesions, following repilation, within 1 month of treatment. The remaining 56,84% showed improvement within 2 months of treatment. Out of all cases where Moxidectin was used, we only observed 3 cases of side effects, which were all related to neurotoxicosis of the drug, which included motor incoordination, muscle shakings and proprioception deficits. All side effects manifested a few time after the ingestion of the drug and disappeared after it was discontinued. It is important to remember that among the cases where side effects occurred, the 1,0 mg/kg dose was being used, and in one of them, decreasing it to 0,5 mg/kg was enough to abolish those adverse effects.

CONCLUSION

According to our experience in using Moxidectin to treat Canine Demodicosis, it is possible to conclude that it is a efficient drug to treat that disease, since it shows a quick response, has an easy administration way, and moreover, showed few incidence of side effects.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Andrea Cristina Higa
Universidade Estadual Paulista - UNESP

Aparecido Antonio Camacho
Universidade Estadual Paulista - UNESP - Campus de Jaboticabal

Daniel Guimaraes Gerardi
Universidade Estadual Paulista - UNESP

Marlos Gonçalves Sousa
FCAV/UNESP.

Mirela Tinucci Costa
Universidade Estadual Paulista - UNESP

Pedro Paulo Vissoto de Paiva Diniz
Universidade Estadual Paulista - UNESP


MAIN : : Moxidectin: Canine Demodicosis
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27